New in PHEO: A Roadmap for Improving US Health Care
In these commentaries, members of the editorial board of Population Health, Equity & Outcomes present their ideas for fixes to the US health care system that could guide health policy efforts post election.
Latest News
View All
Durvalumab Approval Redefines Resectable NSCLC Treatment Strategies
Patients With ILD Face Higher Burden of Fatigue, Excessive Daytime Sleepiness
Treatment Combinations Based in Immune Checkpoint Inhibitors Provide Survival Benefits in CRC
Cost-Effectiveness of a Multicancer Early Detection Test in the US
Uncovering Factors Driving Survival in Hawaiian/Pacific Islander, Asian Indian/Pakistani Patients With Ovarian Cancer
Confronting Systemic Racial Inequities in Health Care Data Must Start With Employers
Small Firms, Big Costs: Employer Health Coverage Disparities
Your Home, Your Health: The Hidden Costs of Housing Insecurity
Unmet Needs in Hemophilia: Prophylaxis, Bleeding, Quality of Life
ICYMI: Highlights From ESC Congress 2024
Race and Immune Microenvironment Impacts on Breast Cancer Outcomes
Rare Blood Disease Innovations Address Unmet Needs, According to ASH Data
Revealing Ovarian Cancer Survival Gaps Among Asian American Subgroups
Access and Equity: Bispecifics for Multiple Myeloma in the Community Setting
Discussing the Pathophysiology of Alopecia Areata
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Vowst as a Potential Option for Patients With Recurrent C Difficile Infections
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Implementing CRM Learnings and Utilization of Telehealth
Confronting Systemic Racial Inequities in Health Care Data Must Start With Employers
Next-Gen Strategies for Resistance in EGFR-Mutated Lung Cancer
Improving Access to Nivolumab by Lowering Age Restrictions in Clinical Trial
Unraveling GLP-1 Agonists and Cardiovascular Protection
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
EMBER-3 Trial: Imlunestrant Plus Abemaciclib Improves Survival in Advanced Breast Cancer
How Anti–CD-38 Antibodies Are Changing the Standard of Myeloma Care
Cost-Effectiveness of a Multicancer Early Detection Test in the US
Provider Capacity During Medicaid Expansion and a Public Health Emergency
Transforming Kidney Care: Policy, Risk Stratification, and Collaborative Models
From Approval to Practice: Addressing the Hurdles in Biosimilar Integration
Navigating the Complexities of Neurological Drug Access
Characteristics of Accountable Care Organizations’ Preferred Skilled Nursing Facility Networks
To Improve Clinical Trial Equity in Multiple Myeloma, Just Ask
Collaborating for Cancer Care Equity: Community and Academic Insights
Elevating Value in Cancer Care With Innovations, Accessibility, Equity
Beyond McKesson and Florida Cancer Specialists, Deals Are Reshaping Community Oncology
Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and Application for Managed Care
Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejection Fraction
Navigating the Evolving Landscape of HER2-Positive Early-Stage Breast Cancer: Considerations for Managed Care
Child Abuse: Responsibilities and Protection of the Reporter
Recent Advances in BCMA-Directed Treatment in Multiple Myeloma: Insights and Application for Managed Care
Managed Care Approaches to Improve Outcomes in Frontline Therapy for Renal Cell Carcinoma
Challenges in Treatment of Desmoid Tumors and Managed Care Solutions
Desmoid Tumors: What Managed Care Professionals Need to Know to Manage These Unpredictable Tumors, featuring a Pharmacy Focus Podcast
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
